ABOUT RGCIRC

Indraprastha Cancer Society and Research Centre is a “not for profit organization”, formed under the Societies Registration Act 1860 and it had set up Rajiv Gandhi Cancer Institute & Research Centre, a standalone oncology care centre, in Delhi, in 1996. The founders of the society are a group of socially responsible selfless philanthropists, who had no financial resources but by dent of their hard work and sheer determination were able to, initially, raise money for running the hospital. Quality, affordability and easy access, for the patients suffering from cancer were the main motivating factors for setting up of the Hospital.

RGCIRC is a great example of a “not for profit organization” supplementing government efforts in the area of healthcare.

RGCIRC is today counted amongst Asia’s premier exclusive cancer centres that offer unique advantage of cutting-edge technology, put to use by renowned super specialists. This potent combination of man and machine ensures world-class cancer care to not only patients from India, but also from the neighboring SAARC countries and others. RGCIRC has touched the lives of more than 3.5 Lakh patients since inception in 1996. The Institute offers super specialized tertiary care services in Medical, Surgical and Radiation Oncology, streamlined into dedicated Site-Specific teams. Super Specialists at RGCIRC practice an organ specific multi-disciplinary approach to cancer diagnosis and treatment, with the Tumor Board acting as a second opinion clinic for cases that are more critical than others. We use front-line technology that helps accurate identification of each patient’s unique cancer and planning of treatment for best possible results. The first hospital in India to begin robotic surgery for cancer patients, first hospital in India to install true beam for precision radiotherapy and first hospital in India to set-up a molecular laboratory. Spread over nearly 2 Lakh square feet area, with a current capacity of 500+ beds along with it’s another unit at Niti Bagh South Delhi, RGCIRC is one of the largest tertiary care centres in the continent. RGCIRC has 14 state-of-the-art well equipped modular Operation Theatres with three stage air filtration and gas scavenging systems, and 3 Minor Operation Theatres for Day Care Surgeries. The Institute has 51 bedded Surgical ICU and a 21 bedded Medical ICU, dedicated Leukemia ward, separate Thyroid Ward, and an independent 22 bedded Bone Marrow Transplant Unit that is credited with pioneering unrelated donor transplants, MUD transplants, and stem cell transplants. Supportive facilities such as Renal Replacement therapies, various endoscopies (including EBUS and Endoscopic Ultrasound) are also available. RGCIRC is committed to bringing the benefits of cutting-edge technology to its patients. The Institute offers best in class techniques such as whole-body Robotic Surgery, Cyber Knife, Tomotherapy, True Beam (the next generation Image Guided Radiation Therapy), Intra-Operative Brachytherapy, PET- MRI fusion, High-Intensity Focused Ultrasound (HIFU), Tomosynthesis (first-of-its-kind revolutionary 3D mammography machine), Nucleic Acid Testing (for safest possible blood), and advanced diagnostic and imaging techniques, including Digital PET CT, Circulating Tumor Cell testing, liquid biopsy, and Next Generation Sequencing. Institute has established Molecular Laboratory for gene profiling, Biorepository (Tissue Bank) for clinical and research purpose and a dedicated Cath Lab for cancer patients has been started to do all interventional radiology procedures, few such as portal venous embolization, carotid artery embolization, TACE, TARE etc. RGCIRC has been consistently ranked amongst India’s Best Oncology Hospitals, and has been the recipient of many awards, including National Business Leadership & Service Excellence Award 2017 for Best Oncology Hospital in India, Indywood Medical Excellence Award 2017, Most Trusted Hospital in Oncology 2017 by India Today (Reader’s Digest), India’s Most Trusted Hospital for Oncology (Readers’ Digest Most Trusted Brands 2016) and Runner up in Finest India Skills & Talent Award 2020 organized by Fire & Security Association of India, Ranked No. 1 (Best Oncology Hospital) in Delhi 2023 by Outlook, Best Specialized Hospital in Asia Pacific region specializing in oncology 2023 by an American Leading Magazine News Week, World’s Best Specialized Hospital 2024 specializing in oncology by News Week, Best Specialized Hospital in Asia Pacific region specializing in oncology 2024 by News Week, World’s Best Specialized Hospital 2025 specializing in oncology by News Week, Outstanding Oncology Treatment Centre at Healthcare Heros Summit and Awards 2025 by Jagran Group and Best Single Specialty Hospital of the year at 15^th MT India Healthcare Awards 2025 by MedGet Today.